A lowered incidence of severe encephalopathy and cardiovascular dysfunction.
Ytrebø
Lars Marius
LM
D000111:Acetylcysteine / Q000627:therapeutic use*; D000818:Animals; D000975:Antioxidants / Q000627:therapeutic use*; D006501:Hepatic Encephalopathy / Q000517:prevention & control*; D006801:Humans; D051381:Rats; D013687:Telencephalon / Q000098:blood supply*
D000975:Antioxidants; D000111:Acetylcysteine